Clinical aspects and cytokine response in severe H1N1 influenza A virus infection - Wikidata - wikimedia - TriplyDB

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

http://www.wikidata.org/entity/Q30396035

about

Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB Two years after pandemic influenza A/2009/H1N1: what have we learned?Review on the impact of pregnancy and obesity on influenza virus infection A Role for Neutrophils in Viral Respiratory Disease.Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity.Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses.Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity.Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection.Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus.Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection.Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6 Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.Obesity and the risk and outcome of infection.Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus.Enhanced Tim3 activity improves survival after influenza infection Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza A (H1N1) virus in mice.Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study.Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice.IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia.Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9 Protocatechuic acid, a novel active substance against avian influenza virus H9N2 infection.The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.CD206+ cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases.Clinical aspects and cytokine response in adults with seasonal influenza infection Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus

P2860

Q26800158-A73495D6-4169-4D4F-8DCC-96AA762397CD Q27310762-4D121502-3237-4673-B8E9-D3627ABC59BA Q28830060-897EF0EE-C062-4373-A475-6F0B863CA7F3 Q30224656-F2970798-0977-40D2-8E79-C5725CBD5779 Q30224744-197888E0-41A1-4CAD-937F-6DD57848D1A6 Q30234336-F825CD91-AB77-47E4-B0E1-F1C0979F805A Q30352743-EF11B559-A904-495E-A4B4-99980E59E003 Q30356646-8E22E191-21AE-4C94-9DA9-A283E8192104 Q30360402-5D183334-52E6-4AB7-95E7-BA4C77EFE002 Q30371441-3D841F2E-E8A0-4957-9D21-7068A4054770 Q30373730-E4100E4B-2812-4C91-83DC-0E78F4AD44C8 Q30375527-48352497-3B43-40C2-B607-125C4B6D47A8 Q30375577-4C75DDD6-C53B-47FE-98C6-398A3A78B4EA Q30382796-458F69D7-6F82-492F-A94F-57E2E8DE1806 Q30398612-302BF777-CA84-456A-AE69-832BC5AA64EE Q30400403-6778A036-7CD2-4FAD-8731-1CDCFFCB62AF Q30403278-9A05A707-C7D7-49CF-9D53-777629FEDC01 Q30403288-D21488F0-072F-4681-8123-46490E5191D7 Q30406363-9E0B30BB-357C-4030-B235-7DF2E325ACEB Q30406559-307661BF-CC80-422B-92B8-FE4F20E68865 Q30408548-9853176B-7CCC-43A5-A498-1AC3A4E8BD16 Q30408586-30193B46-4657-44EC-9F56-D4053DE51191 Q30408784-ACD3DF71-5213-49A6-BFD6-33588BFE920D Q30409432-62103B4C-F574-4230-89B8-22DE6558D742 Q30410746-30531E29-DE8F-4143-BA59-924F0B382433 Q30414286-024E1ECB-0ACF-4570-B430-A7B875902942 Q30416191-4E2999C2-ADB9-4A6C-84D5-2581F0E0B2CA Q30418549-56F3A11D-9845-44A3-8D36-11665D9009C3 Q30420186-2DD7F1DE-2F74-44E6-828E-4D444571D7F8 Q30421004-E2F6774E-DF5E-48C8-A3F6-8B6333EA12E2 Q30423554-2E0E8C95-49DB-4645-BF53-94498EF3DC84 Q30427350-B8E9DC93-B5BD-43B8-B7D5-5931CD85FD28 Q30427596-6C7067B6-B391-4E57-BB75-83A1E88C02E2 Q33799030-567FA89B-812E-4AEC-BEDF-2EFA9D8F5746 Q33864111-A2BAD970-45FF-47EB-A156-112C7B6C94F3 Q34388549-4A8CDCAA-F602-4502-8A0A-6F63E119C40A Q34611788-63787A64-91BC-4EC6-849C-500A52AE7649 Q34968677-32F304D0-843F-4AC5-98E4-FE5EF9E8EDF9 Q35017312-6692137F-3E60-4BB4-AC5C-CD18C6D990A6 Q35746512-9E2D1358-6165-481E-ADD7-8655A064A3AB

P2860

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

http://www.wikidata.org/entity/Q30396035

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@ast

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@en

type

label

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@ast

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@en

prefLabel

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@ast

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@en

P1433

Q30396035-69DED8D5-4348-4828-AEDE-6ABE79E7BE5A

P1476

Q30396035-27D2B945-38BD-4637-8999-BC4D3A69B69B

P2093

Q30396035-24A31BF3-2A6B-4796-9439-0F349B995B2C

Q30396035-2C9FF5A0-EAA3-4DBF-BF94-A9275DECA2F4

Q30396035-375CB016-AED9-4B50-A95E-1752E26A3F64

Q30396035-50B00BB1-64DA-4244-B236-A64994BEDD9A

Q30396035-6B7587AC-2751-41B5-8B8C-9FDC92C084D3

Q30396035-7A5F999B-6F85-4956-8D7D-4BEE67EBE17A

Q30396035-7D8659F7-BF1E-47AE-86A5-1333EE86DDDB

Q30396035-845A017F-4401-4594-8964-FA2F17E822DF

Q30396035-9153F787-8A35-4162-838B-9AD2A15CFE93

Q30396035-99A50DB7-33B9-4FAB-8B63-6134C3684EDC

P2860

Q30396035-16523BD9-039B-4DA6-AC87-11488E965DF5

Q30396035-1A59092C-A82E-4E3E-A9FA-B7D53FA54DF8

Q30396035-2F1616A8-402D-47A9-8F8E-F4BCE58B2DE1

Q30396035-30905338-BC75-4CD8-82FF-4B7745BDD873

Q30396035-44F16DD6-4107-418A-BB88-0F7F65F7A384

Q30396035-4583C324-9C79-430A-98B9-856D0100D458

Q30396035-513C0B83-E948-4FD5-9E2B-F278868343F9

Q30396035-5A712B1E-85F6-482B-9E9E-3DC50E401FD3

Q30396035-62BC99D6-F88B-4094-95C7-57B8991B2390

Q30396035-67BC86A0-069A-438A-8B7B-D80C006B6ECE

P2888

Q30396035-6CB91BDB-6814-48EA-A1E6-6CDA3E1DDD24

P304

Q30396035-E2551E9B-D206-4B64-BF4D-4AE708BE92D3

P31

Q30396035-146C75C7-22F5-4555-9421-53999E7D6C54

P356

Q30396035-D4F3FB69-5891-45D6-A8BD-68FF538BF942

P433

Q30396035-507F4A9B-6A1A-4712-A72B-1C03098C2A33

P478

Q30396035-FCCCF247-89FD-468B-B561-9F77536D788C

P577

Q30396035-CB59DEE5-C0AE-4F8B-9B8C-DCA53B3A1D5D

P5875

Q30396035-E3AF9483-4754-40C0-8A71-FDE053FFDCE3

P6179

Q30396035-07707659-B2BA-4CC2-8F36-B848939C07BF

P698

Q30396035-991F31E2-4695-4942-8EE2-C5A6D8F1FEA0

P932

Q30396035-B845C4FA-1C2C-47CF-8C16-CB9FCA8FFB02

P356

P1433

P1476

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

@en

P2093

Adriana Slavcovici

http://www.w3.org/2001/XMLSchema#string

Carmen Laslo

http://www.w3.org/2001/XMLSchema#string

Constantin Ciuce

http://www.w3.org/2001/XMLSchema#string

Dan S Dirzu

http://www.w3.org/2001/XMLSchema#string

Daniel N Gonganau

http://www.w3.org/2001/XMLSchema#string

Daniela M Studnicska

http://www.w3.org/2001/XMLSchema#string

Erika S Brezoszki

http://www.w3.org/2001/XMLSchema#string

Magda Petrescu

http://www.w3.org/2001/XMLSchema#string

Mihaela Maxim

http://www.w3.org/2001/XMLSchema#string

Monica Mlesnite

http://www.w3.org/2001/XMLSchema#string

P2860

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema

Interleukin-17 and type 17 helper T cells

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

Interleukin 12 a key immunoregulatory cytokine in infection applications

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

Lung pathology in fatal novel human influenza A (H1N1) infection.

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

P2888

P304

R203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC9324

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47728891

http://www.w3.org/2001/XMLSchema#string

P6179

1020655049

http://www.w3.org/2001/XMLSchema#string

P698

21062445

http://www.w3.org/2001/XMLSchema#string

P932

3220006

http://www.w3.org/2001/XMLSchema#string